Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT02243059
Eligibility Criteria:
Inclusion Criteria:
* Non-pregnant female
* Expected FIGO stage IIB-IV epithelial ovarian carcinoma
* Scheduled for primary debulking surgery
* Written informed consent
* At least 18 years of age.
Exclusion Criteria:
* Patients estimated to have more benefit from neoadjuvant chemotherapy
* Ineligibility to undergo MRI
* Non-MR compatible metallic implants or foreign bodies (ferromagnetic aneurysm clip, pacemaker, neurostimulation system, etcetera).
* Claustrophobia
* Ineligibility to receive gadofosveset contrast (history of contrast allergy,
* History of a prior allergic reaction to the active substance or to any of the excipients of Ablavar™.
* Impaired kidney function (Glomerular Filtration Rate \<30 ml/min/1.73m2).
* Previous para-aortic or pelvic lymphadenectomy
* History of a malignant tumour.
* Pregnant or lactating patients. Incapacitated subjects
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02243059
Study Brief:
Protocol Section:
NCT02243059